Calgene charges Enzo with interference

Calgene Inc. on Friday took preemptive action against Enzo Biochem Inc., filing suit to have ENZ's pending antisense patent declared invalid and not infringed by CGNE.

CGNE also asked for damages for statements that it alleges ENZ representatives have made to the public regarding the breadth of its patent and revenues it would realize from CGNE as a licensee.